Estrogen-Related Receptor Alpha (ERRa)-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics

doi 10.21236/ada452545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Protein–protein Interactions as Targets for Small-Molecule Therapeutics in Cancer

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2008English

Epigenetic Information and Estrogen Receptor Alpha Expression in Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2006English

Discovery of Peptidomimetric Antagonists of Estrogen Receptor - Coactivator Interactions: A Novel Strategy to Combat Tamoxifen Drug Resistance

2001English

Estrogen-Related Receptor Alpha Induces the Expression of Vascular Endothelial Growth Factor in Breast Cancer Cells

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2009English

Genome-Independent Hypoxic Repression of Estrogen Receptor Alpha in Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

The Promise of Anti-ErbB3 Monoclonals as New Cancer Therapeutics

Oncotarget
Oncology
2012English

Discovery at the Interface: Toward Novel Anti-Proliferative Agents Targeting Human Estrogen Receptor/S100 Interactions

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Estrogen Receptor-Alpha as a Predictive Biomarker in Endometrioid Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy